DK170804B1 - Komplekser af en eller flere flavanolignaner med et eller flere phospholipider, fremgangsmåde til fremstilling af komplekserne samt farmaceutiske midler indeholdende komplekserne - Google Patents

Komplekser af en eller flere flavanolignaner med et eller flere phospholipider, fremgangsmåde til fremstilling af komplekserne samt farmaceutiske midler indeholdende komplekserne Download PDF

Info

Publication number
DK170804B1
DK170804B1 DK339086A DK339086A DK170804B1 DK 170804 B1 DK170804 B1 DK 170804B1 DK 339086 A DK339086 A DK 339086A DK 339086 A DK339086 A DK 339086A DK 170804 B1 DK170804 B1 DK 170804B1
Authority
DK
Denmark
Prior art keywords
complexes
complex
silybin
flavanolignans
phospholipids
Prior art date
Application number
DK339086A
Other languages
Danish (da)
English (en)
Other versions
DK339086D0 (da
DK339086A (da
Inventor
Bruno Gabetta
Ezio Bombardelli
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11184188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK170804(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of DK339086D0 publication Critical patent/DK339086D0/da
Publication of DK339086A publication Critical patent/DK339086A/da
Application granted granted Critical
Publication of DK170804B1 publication Critical patent/DK170804B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK339086A 1985-07-17 1986-07-16 Komplekser af en eller flere flavanolignaner med et eller flere phospholipider, fremgangsmåde til fremstilling af komplekserne samt farmaceutiske midler indeholdende komplekserne DK170804B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2160285 1985-07-17
IT8521602A IT1215291B (it) 1985-07-17 1985-07-17 Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.

Publications (3)

Publication Number Publication Date
DK339086D0 DK339086D0 (da) 1986-07-16
DK339086A DK339086A (da) 1987-01-18
DK170804B1 true DK170804B1 (da) 1996-01-22

Family

ID=11184188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK339086A DK170804B1 (da) 1985-07-17 1986-07-16 Komplekser af en eller flere flavanolignaner med et eller flere phospholipider, fremgangsmåde til fremstilling af komplekserne samt farmaceutiske midler indeholdende komplekserne

Country Status (18)

Country Link
US (1) US4764508A (cs)
EP (1) EP0209038B2 (cs)
JP (1) JPH0692399B2 (cs)
KR (1) KR890002430B1 (cs)
AR (1) AR241117A1 (cs)
AT (1) ATE46513T1 (cs)
CA (1) CA1259324A (cs)
CS (1) CS257289B2 (cs)
DE (1) DE3665717D1 (cs)
DK (1) DK170804B1 (cs)
ES (1) ES2002101A6 (cs)
FI (1) FI82940C (cs)
GR (1) GR861825B (cs)
HU (1) HU197332B (cs)
IT (1) IT1215291B (cs)
MX (1) MX3173A (cs)
PT (1) PT82988B (cs)
YU (1) YU45790B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1222012B (it) * 1987-07-10 1990-08-31 Indena Spa Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono
EP0464297B1 (en) * 1990-07-05 1995-05-17 INDENA S.p.A. Complexes of neolignane derivatives with phospholipids, the use thereof and pharmaceutical and cosmetic formulations containing them
JP2672439B2 (ja) * 1991-09-25 1997-11-05 倉敷紡績 株式会社 強化押出成形体
GB9211659D0 (en) * 1992-06-02 1992-07-15 Indena Spa New alkaloid derivatives,their use and pharmaceutical formulations containing them
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
IT1274549B (it) * 1995-05-23 1997-07-17 Indena Spa Uso di flavanolignani per la preparazione di medicamenti ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno
US5922757A (en) * 1996-09-30 1999-07-13 The Regents Of The University Of California Treatment and prevention of hepatic disorders
US6218437B1 (en) 1996-09-30 2001-04-17 The Regents Of The University Of California Treatment and prevention of hepatic disorders
ITMI20010429A1 (it) * 2001-03-02 2002-09-02 Indena Spa Composizioni farmaceutiche e cosmetiche per la protezione della pelledai danni indotti dalle radiazioni solari
KR100385366B1 (ko) * 2001-03-05 2003-05-27 부광약품 주식회사 생체이용율을 개선한 실리마린 제제 조성물
ES2288193T3 (es) 2001-07-27 2008-01-01 NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Fosfolipidos naturales de origen marino que contienen flavonoides y fosfolipidos poliinsaturados y sus usos.
JP2005500349A (ja) * 2001-08-01 2005-01-06 アルタナ　ファルマ　アクチエンゲゼルシャフト 呼吸症候群のための選択的ｃｏｘ−２インヒビターと肺表面活性物質の組合せ物
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
ITMI20031388A1 (it) * 2003-07-08 2005-01-09 Indena Spa Formulazioni per il trattamento e la prevenzione di patologie della prostata.
ITMI20051942A1 (it) * 2005-10-14 2007-04-15 S I I T S R L Servizio Interna Composizioni galattogeniche a base di silimarina
RU2319498C2 (ru) * 2005-12-26 2008-03-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Биокомпозиция, обладающая антитоксическим и антиапоптозным действием, профилактическая биологическая добавка на ее основе
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
EP1844785A1 (en) * 2006-04-13 2007-10-17 Indena S.P.A. Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
EP2392326B9 (en) 2007-11-15 2018-09-05 Madaus GmbH Silibinin component for the treatment of hepatitis
CZ300846B6 (cs) * 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
US8337835B2 (en) 2009-04-10 2012-12-25 Washington University Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
IT1395351B1 (it) 2009-07-09 2012-09-14 Axioma Srl Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
MX2012004977A (es) 2009-10-29 2012-11-06 Acasti Pharma Inc Composiciones fosfolipídicas terapéuticas concentradas.
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
ITMI20121784A1 (it) 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
ITMI20130425A1 (it) * 2013-03-20 2014-09-21 Istituto Biochimico Italiano Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (nash)
CN103751785A (zh) * 2014-01-27 2014-04-30 江苏健佳药业有限公司 一种水飞蓟素磷脂复合物及其制备方法
CN104306332B (zh) * 2014-09-24 2017-02-15 东南大学 一种喜树碱类磷脂化合物、其药物组合物及应用
CN105983014A (zh) * 2015-03-23 2016-10-05 天士力制药集团股份有限公司 一种含有水飞蓟宾、ve和左旋肉碱的药物组合物
CN105983016B (zh) * 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
ITUB20155532A1 (it) * 2015-11-12 2017-05-12 St Biochimico Italiano Giovanni Lorenzini Spa Formulazione farmaceutica orale comprendente silibina
IT201600105201A1 (it) 2016-10-19 2018-04-19 Nutrilinea Srl Uso della fosfatidilserina per la prevenzione e il trattamento dei disturbi della prostata e relative composizioni farmaceutiche e nutraceutiche
WO2019070109A1 (es) * 2017-10-03 2019-04-11 Infinite Clinical Research International, S.A. De C.V. Triconjugado para el tratamiento de diabetes mellitus
CA3218320A1 (en) 2021-05-18 2022-11-24 Prostasis, Llc Compositions comprising mixtures of compounds and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5060M (cs) * 1965-12-22 1967-05-08
DE1767666C3 (de) * 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
JPS5958354U (ja) * 1982-10-13 1984-04-16 三菱重工業株式会社 伝熱板
SE442562B (sv) * 1983-01-26 1986-01-13 Asea Ab Sett att innesluta radioaktivt eller annat farligt avfall och en behallare for sadant avfall

Also Published As

Publication number Publication date
FI862850A0 (fi) 1986-07-04
HUT44567A (en) 1988-03-28
DK339086D0 (da) 1986-07-16
PT82988A (en) 1986-08-01
CA1259324A (en) 1989-09-12
AR241117A1 (es) 1991-11-15
CS257289B2 (en) 1988-04-15
DK339086A (da) 1987-01-18
KR890002430B1 (ko) 1989-07-03
FI862850L (fi) 1987-01-18
GR861825B (en) 1986-11-18
IT1215291B (it) 1990-01-31
AR241117A2 (es) 1991-11-15
MX3173A (es) 1993-09-01
EP0209038B2 (en) 1996-03-27
DE3665717D1 (en) 1989-10-26
US4764508A (en) 1988-08-16
YU45790B (sh) 1992-07-20
JPH0692399B2 (ja) 1994-11-16
PT82988B (pt) 1988-07-01
ES2002101A6 (es) 1988-07-16
EP0209038B1 (en) 1989-09-20
JPS6222781A (ja) 1987-01-30
FI82940B (fi) 1991-01-31
EP0209038A1 (en) 1987-01-21
YU128086A (en) 1988-02-29
KR870001188A (ko) 1987-03-12
ATE46513T1 (de) 1989-10-15
IT8521602A0 (it) 1985-07-17
HU197332B (en) 1989-03-28
FI82940C (fi) 1991-05-10

Similar Documents

Publication Publication Date Title
DK170804B1 (da) Komplekser af en eller flere flavanolignaner med et eller flere phospholipider, fremgangsmåde til fremstilling af komplekserne samt farmaceutiske midler indeholdende komplekserne
RU2450818C2 (ru) Фосфолипидные комплексы куркумина, обладающие улучшенной биодоступностью
Jain et al. Phytosome: a novel drug delivery system for herbal medicine
Chung et al. Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells
Amit et al. Phytosome: Phytolipid drug delivery system for improving bioavailability of herbal drug
Rathore et al. Planterosomes: A potential phyto-phospholipid carriers for the bioavailability enhancement of herbal extracts
WO1992006699A1 (en) Plant extracts as mucosal-protective agents
KR20200118456A (ko) 베르베린을 포함하는 조성물
KR100263680B1 (ko) 율무 알맹이로부터 추출된 중성지질 및 이것을 함유한 제약조성물
JP6656316B2 (ja) ハマナツメの使用方法、ハマナツメ抽出物の使用方法及び薬物混合物の使用方法
CS271321B2 (en) Method of isosilybine-free silybine production
KR100694907B1 (ko) 아테롬성동맥경화 치료제로서의 프로안토시아니딘 ａ2의인지질 착체
KR870001020B1 (ko) 실리비닌 유도체의 제조방법
KR100711028B1 (ko) 향나무 추출물 또는 세드롤을 포함하는 비만 및 제2형당뇨병 예방 및 치료용 조성물
Khan et al. Phospholipids: a novel adjuvant in herbal drug delivery systems
Kumar et al. Phytosomes: a noval phyto-phospholipid carriers: an overview
KR102210856B1 (ko) 장 누수 증후군 예방 또는 치료용 약학적 조성물
KR100436428B1 (ko) 간세포 보호 및 간 손상 예방 또는 치료 활성을 나타내는연자육 추출물 및 이를 포함하는 조성물
KR0156039B1 (ko) 제조로부터 의약 추출물을 제조하는 방법 및 그 추출물을 함유하는 간장질환의 예방 및 치료용 의약조성물
KR20040036092A (ko) 진세노사이드 Rh2 및 Rg3 항암 조성물
EP4408196A1 (en) A method of treating cancer
CN100418544C (zh) 获自植物Humboldtia decurrens的抗糖尿病剂及其制备方法
Semalty et al. Supramolecular phospholipids-polyphenolics interactions: The PHYTOSOME (R) strategy to improve the...
FR2658420A1 (fr) Medicaments a base d'atractylis gummifera et varietes alba, lyrata, ovata, humilis, cancellata et leurs derives dans le traitement des pathologies cancereuses de pathologies inflammatoires et pathologies immuno-depressives.
KR20020090248A (ko) 간세포 보호 및 간 손상 예방 또는 치료 활성을 나타내는파슬리 추출물 및 이를 포함하는 조성물

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK